Publication | Closed Access

Discovery and biological evaluation of proteolysis targeting chimeras (PROTACs) as an EGFR degraders based on osimertinib and lenalidomide

Proteomic TechnologyEgfr DegradersMedicineNatural SciencesProteomicsBioanalysisBiotechnologyProtein EngineeringBiological EvaluationTranslational ProteomicsPharmacologyCell BiologyDrug Discovery